SCHEMBL6549255

SCHEMBL6549255

OC(CO/N=C(Cl)/C=C/c1cccnc1)CN1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSF1 Q00613 12/20 0.46
ABCB1 P08183 1/20 0.43
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
HIF1A Q16665 1/20 0.39
ATM Q13315 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
NPC1 O15118 1/20 0.38
JUN P05412 1/20 0.38
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6549259 1.00 HSF1 (0.46) HSF1ABCB1KDM4ESMN1; SMN2CYP2D6
SCHEMBL6550742 0.91 SMN1; SMN2 (0.42) HSF1ABCB1SMN1; SMN2TSHRNPC1
SCHEMBL6550745 0.91 SMN1; SMN2 (0.42) HSF1ABCB1SMN1; SMN2TSHRNPC1
SCHEMBL6548872 0.87 ABCB1 (0.55) HSF1ABCB1KDM4ESMN1; SMN2CYP2D6
Fumaric Acid SCHEMBL6548767 0.86 MEN1 (0.41) ABCB1SMN1; SMN2MAPK1
SCHEMBL6549930 0.86 ABCB1 (0.57) HSF1ABCB1KDM4ECYP2D6TSHR
SCHEMBL6549925 0.86 ABCB1 (0.57) HSF1ABCB1KDM4ECYP2D6TSHR
SCHEMBL28355080 0.81 TAAR1 (0.45) HSF1ABCB1KDM4ESMN1; SMN2CYP2D6
SCHEMBL6548755 0.80 HRH1 (0.45) KDM4ENPC1JUNMAPTNFKB1
SCHEMBL6548752 0.80 HRH1 (0.45) KDM4ENPC1JUNMAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115697-B1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS GENE KUTATO KFT N (HU) 2004-02-04 EP disclosed
US-6500823-B1 ENERGY DEFICIENCY OF THE CELL CAUSED BY PARP INHIBITION, IN DIABETES COMPLICATIONS, IN OXYGEN DEFICIENT STATUS OF THE HEART AND BRAIN, IN NEURODEGENERATIVE DISEASES, IN THE TREATMENT OF AUTOIMMUNE AND/OR VIRAL DISEASES N-GENE RESEARCH LABORATORIES, INC. 2002-12-31 US disclosed
EP-1115697-A1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS N-Gene Kutato KFT. (HU) 2001-07-18 EP disclosed
WO-2000014054-A1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS N-Gene Kutató Kft. (HU) 2000-03-16 WO disclosed